Agilent Technologies Agree to Terms of Sale for Resolution Bioscience to Exact Sciences, Terms Undisclosed
Portfolio Pulse from Benzinga Newsdesk
Agilent Technologies, Inc. (NYSE:A) and Exact Sciences Corp. (NASDAQ:EXAS) have entered into a definitive agreement for the sale of Resolution Bioscience to Exact Sciences. The financial terms of the agreement were not disclosed.
September 12, 2023 | 12:38 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Agilent Technologies has agreed to sell Resolution Bioscience to Exact Sciences. The financial terms were not disclosed.
The sale of Resolution Bioscience to Exact Sciences could potentially impact Agilent Technologies' business operations. However, as the financial terms were not disclosed, it's difficult to predict the exact impact on the company's stock price.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 50
NEUTRAL IMPACT
Exact Sciences Corp. has agreed to acquire Resolution Bioscience from Agilent Technologies. The financial terms were not disclosed.
The acquisition of Resolution Bioscience could potentially impact Exact Sciences' business operations. However, as the financial terms were not disclosed, it's difficult to predict the exact impact on the company's stock price.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 50